Explore how advancements in battery technology and charging infrastructure are shaping India's electric vehicle landscape, ...
Every year in biopharma brings its share of grueling defeats, and 2025 was no different, especially for companies targeting ...
Bristol-Myers Squibb Company ($BMY) announced an update on their ongoing clinical study. Study Overview: Bristol-Myers Squibb ...
NVIDIA is rolling out AI data center reference designs that combine digital twins with power, cooling, and controls ...
Bristol Myers Squibb has become the latest Big Pharma to tie up a biotech pact as we reach the year’s end, tapping Harbour ...
TipRanks on MSN
Bristol-Myers Squibb to launch phase 3 trial for schizophrenia drug KarXT in adolescents
Bristol-Myers Squibb Company ($BMY) announced an update on their ongoing clinical study. Study Overview: Bristol-Myers Squibb ...
San Diego–based Ventyx Biosciences has what pharma wants, according to William Blair: two NLRP3 inhibitors for inflammatory ...
Bristol Myers Squibb has ended the week with an agreement to buy Orbital Therapeutics – a developer of in vivo cell therapies – for $1.5 billion in cash. Cambridge, Massachusetts-based Orbital is ...
Hey fellas,The OEM original 8 year old car battery in my Thar CRDe started to show signs of degradation and I had fun trying ...
GSK’s depemokimab, a long-acting biologic that’s key in the British pharma’s growth plan, has won an endorsement from ...
Starton Holdings plans $40M IPO for cancer drug delivery innovations, but weak IP and limited backing make this a potentially ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback